The combination of a strong Q2 earnings beat with raised guidance and a transformative merger creates significant near-term catalysts. Monitor for shareholder votes (both companies) and regulatory approvals needed for Q4 2026 close. The fixed exchange ratio means relative stock performance between INDV and SUPN will drive value for each shareholder group. Note the $1B special dividend for pre-closing Indivior shareholders and the ~$650M of debt to be drawn to fund it.
Price Chart
Executive Summary
Indivior reported record Q2 2026 results with total net revenue of $343M (up 14% YoY), record SUBLOCADE revenue of $253M (up 21% YoY), record adjusted EBITDA of $186M (up 111% YoY), and raised full-year 2026 guidance. Concurrently, Indivior announced a transformative stock-for-stock merger with Supernus Pharmaceuticals (exchange ratio 1.5401) expected to close in Q4 2026, creating a diversified CNS leader with ~$2.2B in pro forma combined revenue and at least $125M in expected annual cost synergies, plus a $1B special dividend to pre-closing Indivior shareholders.
Key Facts
- Q2 2026 total net revenue of $343 million, up 14% year-over-year
- Record quarterly SUBLOCADE net revenue of $253 million, up 21% YoY
- Record quarterly GAAP net income of $122 million
- Record quarterly adjusted EBITDA of $186 million, up 111% YoY
- Repurchased approximately 4.7 million shares for $175 million in Q2 2026
- Raised full-year 2026 guidance
- Announced stock-for-stock merger with Supernus Pharmaceuticals at 1.5401 exchange ratio
- $1 billion special dividend to be paid to pre-closing Indivior stockholders
- Expected annual cost synergies of at least $125 million
- Pro forma combined LTM net revenue of $2,162 million and adjusted EBITDA of $888 million (41% margin)
- Target close in Q4 2026; combined company to be named Supernus, Inc., headquartered in Rockville, MD
Financial Impact
Transformative merger creating a ~$2.2B CNS leader with $125M+ annual synergies; strong Q2 beat with 14% revenue growth and 111% adjusted EBITDA growth; raised full-year guidance; $1B special dividend distributed to Indivior shareholders pre-close
Risk Factors
- Merger may not close in Q4 2026 or at all due to shareholder or regulatory approvals
- Integration risk and potential failure to realize $125M+ cost synergies
- Additional $650M debt to fund special dividend increases combined leverage to ~0.99x net leverage
- Fixed exchange ratio exposes each shareholder group to relative stock price movements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (INDV) — Batch item 1 | 0001193125-26-329620 |
| Document: 0001193125-26-329620-index-headers.html | 0001193125-26-329618 |
| Document: 0001193125-26-329620-index.html | 0001193125-26-329620 |
| Document: 0001193125-26-329620.txt | 0001193125-26-329620 |
| 8-K Filing (INDV) — Batch item 5 | 0001193125-26-329618 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | EFFECT | $34.47 $35.53 | ▲ +3.08% | ▲ +2.97% | $35.71 (+3.60%) |
Aug 28, 2026 4w ago | S-4 | $34.93 $34.32 | ▼ −1.75% | ▼ −1.60% | $35.71 (+2.23%) |
Aug 3, 2026 8w ago | 425 / 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 425 | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 425 / 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Jul 23, 2026 10w ago | Press Release | $40.51 $40.22 | ▼ −0.72% | ▼ −1.19% | $35.71 (−11.85%) |
Jun 12, 2026 16w ago | Insider Cluster | $38.40 $38.32 | ▼ −0.21% | ▲ +1.17% | $35.71 (−7.01%) |
May 15, 2026 20w ago | 8-K | $36.54 $37.81 | ▲ +3.48% | ▲ +1.86% | $35.71 (−2.27%) |
May 4, 2026 21w ago | 8-K | $38.98 $38.84 | ▼ −0.36% | ▼ −3.30% | $35.71 (−8.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access